{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:38:31Z","timestamp":1790667511669,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.antiviral.2019.104588","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T19:52:05Z","timestamp":1565639525000},"page":"104588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-\u03baB-RIPK1-caspase axis"],"prefix":"10.1016","volume":"170","author":[{"given":"Changbo","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifa","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Donkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan F.J.","family":"van de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maikel P.","family":"Peppelenbosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104588_bib1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/MCB.01430-12","article-title":"Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands","volume":"33","author":"Apelbaum","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2019.104588_bib2","first-page":"19","article-title":"Viral modulation of cell death by inhibition of caspases","volume":"51","author":"Cassens","year":"2003","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.antiviral.2019.104588_bib3","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.01337-15","article-title":"Inhibition of Ebola and marburg virus entry by G protein-coupled receptor antagonists","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104588_bib4","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/cdd.2017.59","article-title":"Viral hijacking of host caspases: an emerging category of pathogen-host interactions","volume":"24","author":"Connolly","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.antiviral.2019.104588_bib5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4254\/wjh.v6.i6.426","article-title":"Hepatitis E virus in patients with acute severe liver injury","volume":"6","author":"Crossan","year":"2014","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104588_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.18632\/oncotarget.13537","article-title":"New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.antiviral.2019.104588_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2015.09.011","article-title":"Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin","volume":"150","author":"Dao Thi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2019.104588_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00228-005-0065-z","article-title":"The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands","volume":"62","author":"de Vries","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.104588_bib9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2014.08.040","article-title":"A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients","volume":"147","author":"Debing","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2019.104588_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2016.05.002","article-title":"Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity","volume":"65","author":"Debing","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104588_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.dld.2010.02.016","article-title":"A review of mast cells and liver disease: what have we learned?","volume":"42","author":"Francis","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.antiviral.2019.104588_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lfs.2018.07.022","article-title":"Regulation of apolipoprotein A-I gene expression by the histamine H1 receptor: requirement for NF-kappaB","volume":"208","author":"Haas","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.antiviral.2019.104588_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1964","article-title":"Immunity against hepatitis E virus infection: implications for therapy and vaccine development","volume":"28","author":"Hakim","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.104588_bib14","doi-asserted-by":"crossref","first-page":"27597","DOI":"10.1038\/srep27597","article-title":"The ORF3 protein of genotype 1 hepatitis E virus suppresses TLR3-induced NF-kappaB signaling via TRADD and RIP1","volume":"6","author":"He","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104588_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010286","article-title":"Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection","volume":"7","author":"He","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2019.104588_bib16","article-title":"Hepatitis C virus nonstructural protein 5A inhibits mg132-induced apoptosis of hepatocytes in line with NF-kappaB-Nuclear translocation","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104588_bib17","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104588_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104588_bib19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2468-1253(16)30242-4","article-title":"Direct-acting antiviral therapy for hepatitis E virus?","volume":"2","author":"Kamar","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104588_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.canlet.2005.03.030","article-title":"State of hepatitis C viral replication enhances activation of NF-kB- and AP-1-signaling induced by hepatitis B virus X","volume":"234","author":"Kanda","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.antiviral.2019.104588_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2018.10.007","article-title":"RIP kinases in liver cell death, inflammation and cancer","volume":"25","author":"Kondylis","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.antiviral.2019.104588_bib22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41556-018-0229-6","article-title":"TBK1 and IKKepsilon prevent TNF-induced cell death by RIPK1 phosphorylation","volume":"20","author":"Lafont","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.104588_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2017.04.002","article-title":"Visualization of hepatitis E virus RNA and proteins in the human liver","volume":"67","author":"Lenggenhager","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104588_bib24","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1002\/jcp.27144","article-title":"Epstein-Barr virus and thyroid cancer: the role of viral expressed proteins","volume":"234","author":"Moghoofei","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.antiviral.2019.104588_bib25","doi-asserted-by":"crossref","first-page":"21124","DOI":"10.1074\/jbc.M701696200","article-title":"The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death","volume":"282","author":"Moin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104588_bib26","doi-asserted-by":"crossref","first-page":"19541","DOI":"10.1073\/pnas.0707947104","article-title":"Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification","volume":"104","author":"Moody","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104588_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00003-19","article-title":"Antiviral candidates for treating hepatitis E virus infection","volume":"63","author":"Netzler","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104588_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tcb.2015.01.001","article-title":"RIPK1 and RIPK3: critical regulators of inflammation and cell death","volume":"25","author":"Newton","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.antiviral.2019.104588_bib29","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1099\/vir.0.79958-0","article-title":"Active NF-kappaB signalling is a prerequisite for influenza virus infection","volume":"85","author":"Nimmerjahn","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104588_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-kappaB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2019.104588_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/JVI.01434-06","article-title":"Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication","volume":"81","author":"Ozawa","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104588_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00109-009-0470-3","article-title":"Combined antiviral activity of interferon-alpha and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing","volume":"87","author":"Pan","year":"2009","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.antiviral.2019.104588_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01914-16","article-title":"Clinically approved ion channel inhibitors close gates for hepatitis C virus and open doors for drug repurposing in infectious viral diseases","volume":"91","author":"Pietschmann","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104588_bib34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2119\/2007-00055.Prusty","article-title":"Selective suppression of NF-kBp 65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality","volume":"13","author":"Prusty","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.antiviral.2019.104588_bib35","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1007\/s00705-017-3444-8","article-title":"Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin","volume":"162","author":"Qu","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2019.104588_bib36","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1096\/fj.201800620R","article-title":"Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target","volume":"33","author":"Qu","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.antiviral.2019.104588_bib37","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1038\/cddis.2012.18","article-title":"Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis","volume":"3","author":"Richard","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.antiviral.2019.104588_bib38","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1365-2222.2008.02990.x","article-title":"Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms","volume":"38","author":"Roumestan","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.antiviral.2019.104588_bib39","doi-asserted-by":"crossref","first-page":"41620","DOI":"10.1074\/jbc.M103674200","article-title":"Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-alpha phosphorylation","volume":"276","author":"Saelens","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104588_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1023\/A:1019587826187","article-title":"Anti-asthmatic drugs and dosage forms in children: a cross-sectional study","volume":"24","author":"Schirm","year":"2002","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.antiviral.2019.104588_bib41","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1016\/j.bbamcr.2014.08.004","article-title":"The intricate interplay between RNA viruses and NF-kappaB","volume":"1843","author":"Schmitz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2019.104588_bib42","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2","article-title":"Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma","volume":"89","author":"Tai","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.antiviral.2019.104588_bib43","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/gutjnl-2015-311000","article-title":"In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome","volume":"65","author":"Todt","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2019.104588_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2018.07.010","article-title":"The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo","volume":"157","author":"Todt","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104588_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.01.005","article-title":"Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication","volume":"140","author":"Wang","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104588_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aah4248","article-title":"Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections","volume":"10","author":"Wang","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.antiviral.2019.104588_bib47","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1128\/AAC.02700-15","article-title":"Cross talk between nucleotide synthesis pathways with cellular immunity in constraining hepatitis E virus replication","volume":"60","author":"Wang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104588_bib48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm.3826","article-title":"Activation of AMPKalpha2 in adipocytes is essential for nicotine-induced insulin resistance in vivo","volume":"21","author":"Wu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2019.104588_bib49","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/hep.29105","article-title":"RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production","volume":"65","author":"Xu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104588_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fmicb.2018.00460","article-title":"Hepatitis E virus induces hepatocyte apoptosis via mitochondrial pathway in Mongolian gerbils","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104588_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2015.10.016","article-title":"Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication","volume":"124","author":"Zhou","year":"2015","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:40Z","timestamp":1759062700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219302979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":51,"alternative-id":["S0166354219302979"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104588","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-\u03baB-RIPK1-caspase axis","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104588"}}